Krishna Kavi

Krishna is a seasoned FDA and healthcare regulatory attorney with deep experience at top-tier Am Law 50 firms and in-house at a pioneering digital health company. She helps clients across the life sciences, digital health, and AI/ML ecosystem navigate complex FDA regulations, manage risk, and bring innovative products to market with confidence.

With a focus on digital health, Software as a Medical Device (SaMD), Prescription Digital Therapeutics (PDTs), AI, food, cosmetics, and supplements, and alternative medicine and wellness products, Krishna partners with clients at every stage of the product lifecycle from development and launch to post-market enforcement and defense.

Krishna has practiced at nationally ranked law firms including King & Spalding and Norton Rose Fulbright at their Washington, DC and New York City offices, representing pharmaceutical, biotech, medical device, food, cosmetic, and supplement companies on high-stakes regulatory, investigation, transaction, and compliance matters.

She also served as Associate Director, Counsel at Pear Therapeutics, a trailblazer in digital therapeutics, where she provided legal leadership across Regulatory, Commercial, Product, and Compliance teams. This dual perspective allows Krishna to offer clients practical, business-minded counsel that aligns with internal operations and external risk.

In addition to helping clients with their core business functions, Krishna has counseled clients to successful outcomes on critical FDA and healthcare matters from settling DOJ and OIG fraud and abuse investigations to resolving FDA enforcement actions.